Last reviewed · How we verify

Fondation pour l'accueil et l'hébérement des personnes âgées — Portfolio Competitive Intelligence Brief

Fondation pour l'accueil et l'hébérement des personnes âgées pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
Cannabis Sativa Oil Cannabis Sativa Oil marketed Phytocannabinoid preparation CB1 receptor, CB2 receptor Pain management, Neurology, Immunology

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. Assaf-Harofeh Medical Center · 1 shared drug class
  2. Thammasat University Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Fondation pour l'accueil et l'hébérement des personnes âgées:

Cite this brief

Drug Landscape (2026). Fondation pour l'accueil et l'hébérement des personnes âgées — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/fondation-pour-l-accueil-et-l-h-b-rement-des-personnes-g-es. Accessed 2026-05-17.

Related